Clinical Trial

Impact of HIV-1 and Aging on Mucosal Vaccine Responses

Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this study is to learn more about both HIV-1 infection and advancing age, and their association with increased risk of serious infection and impaired response to the Prevnar 13 vaccine.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2018-10-31; most recent amendment 2026-06-26.
Status change: Recruiting → Active, Not Recruiting 2024-07-11
Trial Details
NCT Number NCT03729778
Lead Sponsor VA Eastern Colorado Health Care System
Conditions HIV-1-infection, Human Immunodeficiency Virus, HIV/AIDS, HIV Infections
Enrollment 100 participants
Start Date 2017-01-18
Primary Completion 2020-03-31 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-29